Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Boston Scientific Corp (NYSE:BSX)

26.38
Delayed Data
As of Apr 28
 +0.20 / +0.76%
Today’s Change
19.67
Today|||52-Week Range
26.47
+21.96%
Year-to-Date
Boston Scientific (BSX) Misses on Q1 Earnings, Updates View
Apr 27 / Zacks.com - Paid Partner Content
Boston Scientific's Latest Quant Upgrade Reaffirms a Breakout Ahead
Apr 24 / TheStreet.com - Paid Partner Content
Boston Scientific (BSX): Beats on Q1 Sales, Misses Earnings
Apr 27 / Zacks.com - Paid Partner Content
Will Boston Scientific (BSX) Surprise this Earnings Season?
Apr 21 / Zacks.com - Paid Partner Content
Analysts' Actions -- Amazon, C.R. Bard, CyrusOne, Dow and More
Apr 25 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close26.18
Today’s open25.97
Day’s range25.97 - 26.47
Volume9,033,424
Average volume (3 months)7,908,363
Market cap$36.1B
Dividend yield--
Data as of 4:00pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+12.35%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)+13.34%
P/E ratio105.5
Price/Sales3.55
Price/Book5.34

Competitors

 Today’s
change
Today’s
% change
BDXBecton Dickinson and...+4.42+2.42%
ZBHZimmer Biomet Holdin...+1.55+1.31%
BCRC R Bard Inc+1.90+0.62%
TFXTeleflex Inc+0.43+0.21%
Data as of 4:03pm ET, 04/28/2017

Financials

Last reporting dateApril 27, 2017
EPS forecast (this quarter)$0.30
Annual revenue (last year)$8.4B
Annual profit (last year)$347.0M
Net profit margin4.14%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael F. Mahoney
Executive Vice President-
Operations
Edward Mackey
Corporate headquarters
Marlborough, Massachusetts

Forecasts